Generation and characterization of a preventive and therapeutic HPV DNA vaccine
- 17 January 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (3), 351-360
- https://doi.org/10.1016/j.vaccine.2007.11.019
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2Journal of Virology, 2007
- Vaccination of Healthy Volunteers with Human Papillomavirus Type 16 L2E7E6 Fusion Protein Induces Serum Antibody that Neutralizes across Papillomavirus SpeciesCancer Research, 2006
- A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effectsGene Therapy, 2005
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001
- Human Papillomavirus Type 16 E6-Induced Degradation of E6TP1 Correlates with Its Ability To Immortalize Human Mammary Epithelial CellsJournal of Virology, 2001
- DNA VACCINESAnnual Review of Immunology, 1997
- Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAPImmunity, 1996
- Heat Shock-sensitive Expression of Calreticulin.Journal of Biological Chemistry, 1995
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993